NxStage Medical Inc.
NxStage gains on Q4, 2014 beats, opens Boston dialysis centers
NxStage Medical wins FDA nod for nocturnal home dialysis
Pulmonx taps ex-Asthmatx CEO French for the corner office | Personnel Moves
Pulmonx said yesterday that it named Glen French, the co-founder and CEO of Asthmatx who led it to an acquisition by BSX, to be its new president and chief executive.
Ex-Boston Scientific CEO Tobin joins Oxford Immunotec board | Personnel Moves
NxStage study highlights advantages of home hemodialysis
Press Release: NxStage announces FDA clearance of Single Needle Technology
LAWRENCE, Mass. —
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite, has received FDA clearance.
NxStage Medical’s single-needle home dialysis system comes to the U.S.
Massachusetts-based dialysis devices maker NxStage Medical (NSDQ:NXTM) won FDA clearance for its OneSite technology, cutting down on the number of needles dialysis patients must endure during therapy.
HeartWare nabs JenaValve exec Leadley for medical chief | Personnel Moves
What medtech companies is BlackRock buying into?
NxStage Medical tops Q4, 2013 estimates
NxStage Medical (NSDQ:NXTM) shares rose today after the medical device company said it just beat estimates with its results for the 4th quarter and last year.